KLC
CDLX icon

Kent Lake Capital’s Cardlytics CDLX Stock Holding History

Kent Lake Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,000
Closed -$3.62M – 46
2024
Q1 		$3.62M Buy
+25,000
New +$2.11M 1.58% 25
2023
Q2 		– Sell
-2,694
Closed -$91.5K – 52
2023
Q1 		$91.5K Buy
+2,694
New +$141K 0.06% 35

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $150M AUM 4.49% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kent Lake Capital's CDLX Position: Q2 2024 in Review

Kent Lake Capital sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 25,000 shares — an estimated $3.62M sold.

Kent Lake Capital first reported a position in CDLX in Q1 2023 and held it in 2 quarters. The position peaked at $3.62M in Q1 2024. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Kent Lake Capital reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Kent Lake Capital sold 25,000 Cardlytics shares in Q2 2024, an estimated $3.62M.
  • Kent Lake Capital first reported a position in Cardlytics in Q1 2023 and held it in 2 quarters.
  • Kent Lake Capital's Cardlytics position peaked at $3.62M in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.